Kairos Pharma to sell 1.55 million shares in IPO at $4 each
Kairos Pharma plans to sell about 1.55 million shares in its initial public offering at $4 per share.
“In short, market participants seem to agree with this thesis—in a world in which the government decides to keep the...
“Our agent thinks it would be best if we just put a down payment on the new house and invest...
Morgan Stanley’s Mike Wilson has been one of the most cautious voices on Wall Street, but even caution can become...
“It’s odd that, in life, loss and money can be so tied up — that death can be a financial...
Oil futures edged higher early Monday, attempting to build on last week’s strong gains, which were scored after the Federal...
The popular Netflix reality series follows L.A. real estate agents as they market lavish megahomes in Southern California.